SARS-CoV-2 Nucleocapsid antibody (C-Term)

Catalog No. ABIN7272991

Product Details anti-SARS-CoV-2 Nucleocapsid Antibody

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Binding Specificity: C-Term

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Goat

Clonality: Polyclonal

Conjugate: This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

Application: Western Blotting (WB)

Cross-Reactivity (Details): Reacts with SARS-CoV-2 protein

Purification: Epitope affinity purified

Immunogen: Affinity purified recombinant fusion protein using the C-terminal of Nucleocapsid (residues 280 to stop) and produced in E. coli

Isotype: IgG

Application Details

Application Notes: WB:1:500-1:2,000

Comment:

In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.

Restrictions: For Research Use only

Handling

Concentration: 3 mg/mL

Buffer: PBS, 20 % glycerol and 0.05 % sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at -20 °C for long-term storage. Store at 2-8 °C for up to one month.

Target Details for SARS-CoV-2 Nucleocapsid

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Alternative Name: Nucleocapsid (SARS-CoV-2) (SARS-CoV-2 N Products)

Synonyms: nucleocapsid phosphoprotein antibody, N antibody

Target Type: Viral Protein